Copycat investing: how to evaluate a lead VC's deal

Brian Nichols is the co-founder of Angel Squad, an angel investing community where aspiring and active angels learn from Hustle Fund’s approach, review curated deal flow, and connect with peers.

A familiar investor's name can make a deal feel easier to judge. You see a respected venture firm leading a startup round, and the deadline suddenly feels more urgent. Understanding what you can learn from that investor, and what remains unknown, helps you decide whether the opportunity deserves your own money.

What is copycat investing?

Copycat investing means choosing investments because another investor owns them or has bought them. In public markets, it's often called coattail investing. An investor might copy stocks disclosed by a fund manager or use a copy-trading service that mirrors another person's trades.

Following a venture capitalist (VC) into a private startup round is a different arrangement. A lead investor helps organize a financing and may negotiate its terms. Other investors can participate directly or through a vehicle that pools their checks. That participation is co-investing. It becomes blind copying when the lead's name is your entire reason for investing.

The differences affect what you know and what you can buy:

• Public-stock copying uses disclosed holdings. The U.S. Securities and Exchange Commission (SEC) requires certain institutional managers to report quarter-end securities holdings on Form 13F. Filings are generally due within 45 days of quarter-end, and short positions aren't reported. The SEC's Form 13F guidance explains those limits. A filing doesn't reveal the manager's full portfolio, investment reasoning, or whether a disclosed position is still held.
• Automated copy trading follows a platform's execution rules. What gets copied, the timing, costs, and supported assets depend on the service. It doesn't guarantee the copied trader's results.
• Startup co-investing depends on a specific offering. Access, eligibility, documents, and available allocation determine whether you can participate. Owning the same company's securities doesn't necessarily give you the lead investor's price, rights, information, or fees.

Private startup investments also have a different exit problem. The SEC's private-placement investor bulletin warns about limited disclosure, illiquidity, and possible total loss. You may have to hold an investment indefinitely. A recognizable lead doesn't remove those risks.

What a lead VC can contribute

An experienced venture capitalist can bring useful knowledge about a sector, founder references, customer behavior, and financing terms. Their participation can also bring a board relationship, recruiting help, or introductions after the investment. The value depends on what the particular investor does.

In a 2016 survey of 885 VCs, published by the National Bureau of Economic Research, Paul Gompers and his co-authors studied investors at 681 firms. Respondents rated the management team as more important in selection than business characteristics such as the product or technology. They also described sourcing, selection, and post-investment support as contributors to value creation.

That survey describes how VCs make decisions. It doesn't establish that copying a particular firm produces better returns at a particular funding stage.

The useful information is the lead's reasoning. A statement such as “we spoke with customers who renewed despite a price increase” gives you something to assess. “A famous fund is in” tells you little about demand, retention, or the price you're paying.

At Angel Squad, we share curated opportunities with context on the founders, terms, and why Hustle Fund invested. Members can learn from that reasoning and discuss it with peers. Each investor still makes their own decision, including whether to pass.

Funding stage changes the evidence available

Product-market fit is a useful lens for evaluating the business. It means a product meets meaningful demand in a defined market. For an investment decision, we also want evidence about whether customers stay, whether the company can reach more of them, and whether serving them makes economic sense.

A seed round, Series A, or Series B is a financing label. It doesn't establish product-market fit. Michael Seibel's product-market-fit explanation makes the distinction directly: a major funding round is different evidence from growing demand among happy, loyal customers.

When operating evidence is sparse

A young startup may have a prototype, a few customers, or early revenue. Those can be useful signals, but they leave open questions about repeat purchases, sales beyond the founder's network, and the cost of delivering the product.

Our co-founder and general partner Elizabeth Yin cautions in Democratizing Knowledge (2021, PDF page 126) that it's “near impossible to tell” which early-stage companies will become outliers. That's a reason to be humble about a prediction. Diligence still helps you understand the bet you're making.

Focus on the team's knowledge of the customer, the urgency of the problem, and what the company has learned from actual usage. A founder who can explain why customers left, what changed, and how customers responded gives you more substance than a confident growth forecast.

When there is more operating history

A business with several years of activity may have revenue records, renewal data, customer cohorts, and acquisition costs you can analyze. A cohort is a group of customers who started during the same period; comparing cohorts helps you see whether newer customers behave like earlier ones.

More history makes some questions easier to answer. It also exposes risks that a headline growth figure can hide:

• Retention: Do customers continue using and paying for the product after the first contract or promotion?
• Acquisition: Can the company win customers outside the founders' personal network without spending more than those customers contribute?
• Customer concentration: Is growth spread across customers, or does one large account drive it?
• Delivery economics: How much revenue remains after the direct cost of serving customers, including support and infrastructure?
• Cash needs: What must the new capital accomplish, and how dependent is the plan on another financing?

A lead investor can help interpret that evidence. Their involvement still doesn't make the price attractive or guarantee an exit. Product-market fit can also weaken as competition, customer needs, or distribution channels change.

Keep the financing stage in the context of your analysis. The decision still depends on the business, your terms, and your portfolio.

The same company can be a different investment

A startup can be promising while the offering available to you is a poor fit. Separate your view of the business from your view of the security, meaning the shares or contractual investment you're buying.

These differences deserve their own part of your investment memo:

1. Entry timing and price. A fund listed on the company's website may have invested years earlier. Its continued presence doesn't mean it is buying the current round at your price.
2. Instrument and rights. The lead may hold preferred shares, which have specified financial or governance rights. Your opportunity might involve a different share class or a Simple Agreement for Future Equity (SAFE), a contract that can convert into equity under specified conditions. A SAFE's valuation cap is a conversion term, not proof of the company's value.
3. Participation route and costs. A special purpose vehicle (SPV) pools investors' capital into an entity that holds the investment. Its fees and carried interest, a manager's share of specified profits, can change your economics. Its documents also determine how decisions and information reach you.
4. Information and influence. A board seat or contractual reporting rights may give the lead access and influence you don't have. The lead's confidence can rest on information absent from your materials.
5. Follow-on capacity. A venture fund may have capital reserved for later rounds. Your ability or willingness to invest again may be different. Rights to participate in future rounds depend on the documents and don't guarantee an allocation.

For example, a pitch might say a well-known firm “backs the company.” If that firm bought an earlier round and isn't investing now, the statement describes a historical relationship. It provides no current investment thesis from that firm.

The signed documents determine your investment. A shared company name or headline valuation can't establish that you're getting the same deal.

Turn the lead's conviction into your own decision

A useful decision process covers the business, the terms, and your portfolio. Give each a separate answer so strength in one area doesn't hide a weakness in another.

The 5T startup evaluation framework we explored with investor Sandy Naidu organizes team, target market, technology, traction, and terms. The discipline is useful even when your criteria differ from that investor's. Our angel-investing diligence checklist expands the customer, founder, financial, and document questions behind a memo.

Before committing capital, write a short memo with five parts:

1. The business case. Name the customer, the problem, why this product wins business, and what must happen for the company to grow.
2. The evidence. Record customer conversations, usage, revenue, retention, and founder references. Separate observed results from management forecasts and the lead's opinions.
3. The unanswered questions. Name the biggest missing information and whether you're comfortable making the investment without it. Missing data belongs in the decision.
4. Your terms. Describe the instrument, price or conversion terms, material rights, costs, and transfer restrictions available to you.
5. Your portfolio decision. Record the check size, remaining startup budget, possible follow-on needs, and overlap with existing investments. Include a clear invest or pass reason.

Elizabeth Yin writes in Democratizing Knowledge (2021, PDF page 131): “The more disciplined you are in your thought process/rubric, the more you can improve over time.” A written memo preserves what you believed when you invested, so later company updates can show where your reasoning held up or fell short.

Two hypothetical situations show how this works without predicting returns:

• A seed startup has strong founder references and early customer enthusiasm. A respected lead is investing, but there is little renewal history. Your memo should describe the uncertainty around durable demand and distribution. The lead's name can't answer it.
• A Series B company has years of revenue and renewal data. The business evidence is stronger, but your participation carries additional fees and limited reporting rights. You can like the company and pass on that offering.

Your check also sits inside your own finances. A loss that a diversified venture fund can absorb may be painful for an angel with a few investments. Plan for the possibility that most of your startup bets fail. Several companies exposed to the same customers, funding conditions, or technology trend can struggle together, even if different famous firms backed them.

Passing is a complete decision when the evidence, terms, or portfolio fit aren't sufficient. You don't need to match someone else's risk tolerance to learn from their work.

To practice evaluating startup opportunities with investing education, deal context, and peers, apply to Angel Squad.

This is general education, not investment, legal, tax, accounting, or valuation advice. Private startup investments are speculative, illiquid, and long-term, and you can lose your entire investment. Seek independent review of the governing documents and your circumstances from qualified investment, legal, and tax professionals.